Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Breast ; 31: 16-19, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27810693

RESUMEN

OBJECTIVES: Randomized trials involving aromatase inhibitors (AIs) in the adjuvant treatment of breast cancer patients have reported increased osteoporosis risk. Bone loss can be reduced with appropriate life style, vitamin D and calcium supplements, and with bisphosphonate therapy. The aim of this analysis was to investigate adherence to vitamin D and calcium in postmenopausal breast cancer patients receiving adjuvant non-steroidal AIs, and oncologists' adherence to the bone health guidelines. MATERIAL AND METHODS: This prospective study included 438 newly diagnosed patients and those who have already been receiving non-steroidal AIs for up to 3.5 years. Median endocrine therapy duration before recruitment in the study was 10.5 months (interquartile 4.8-26.6). RESULTS: Densitometry was performed on 142 patients (32.4%) before initiation of endocrine therapy, and on additional 38 (8.6%) patients at second study visit. Densitometry was not performed on 258 (59%) patients. Vitamin D and calcium were prescribed to 329/438 (75.1%) patients at some point during the study. Patients who took more than 80% of the prescribed dose were considered adherent. Self-reported adherence was 88.4%. Osteoporosis was diagnosed in 24 patients (5.5%) of the total study population, bearing in mind that 258/438 (59%) patients did not have densitometry. Bisphosphonates were prescribed to 54/438 (12.3%) patients, whilst only 19 (35.2%) of those had osteoporosis. CONCLUSION: In this analysis, lack of oncologists' adherence to the bone health guidelines was observed. In addition, a significant proportion of the patients did not adhere to the vitamin D and calcium.


Asunto(s)
Conservadores de la Densidad Ósea/administración & dosificación , Neoplasias de la Mama/tratamiento farmacológico , Adhesión a Directriz/estadística & datos numéricos , Cumplimiento de la Medicación/estadística & datos numéricos , Osteoporosis/prevención & control , Guías de Práctica Clínica como Asunto , Adulto , Anciano , Anciano de 80 o más Años , Inhibidores de la Aromatasa/efectos adversos , Densidad Ósea/efectos de los fármacos , Neoplasias de la Mama/patología , Neoplasias de la Mama/psicología , Calcio/administración & dosificación , Calcio/normas , Croacia , Suplementos Dietéticos/normas , Difosfonatos/administración & dosificación , Difosfonatos/normas , Prescripciones de Medicamentos/estadística & datos numéricos , Quimioterapia Combinada/normas , Femenino , Humanos , Persona de Mediana Edad , Osteoporosis/inducido químicamente , Estudios Prospectivos , Vitamina D/administración & dosificación , Vitamina D/normas , Vitaminas/administración & dosificación , Vitaminas/normas
2.
Drug Test Anal ; 8(3-4): 410-2, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27072845

RESUMEN

The Dietary Supplement Health and Education Act of 1994 (DSHEA), which arbitrarily classified herbals and other medicinal products as dietary supplements, obscured fundamental differences between two classes of products. Authentic supplements to the diet, such as multivitamins or calcium, have nutritional value and are safe. Herbals are used worldwide as medicines, they do not supplement the diet, they may cause severe adverse events, and they should be regulated as medicines. DSHEA also prevented the Food and Drug Administration (FDA) from effectively regulating herbal supplements as medicines. One consequence of weak FDA regulatory oversight is the poor quality of herbals. FDA inspections of manufacturing facilities have revealed violations of good manufacturing practices in over half of facilities inspected, including unsanitary conditions and lack of product specifications. Moreover, many "all natural" herbals marketed for weight loss, enhancement of sexual health and improving sports performance are adulterated with prescription and over-the-counter medications that have caused adverse cardiovascular events. New procedures to authenticate the identity of plants used in herbals will neither detect adulteration by medications nor provide assurance of appropriate pharmacological activity or safety. Nonvitamin, nonmineral "supplements" should be regulated as medicines, but revision or repeal of DSHEA faces strong opposition in Congress. The marketing of botanical supplements is based on unfounded claims that they are safe and effective. Health professionals need to inform patients and the public that there is no reason to take herbal medicines whose composition and benefits are unknown, and whose risks are evident.


Asunto(s)
Suplementos Dietéticos/normas , Legislación de Medicamentos , Legislación Alimentaria , Calcio/efectos adversos , Calcio/normas , Suplementos Dietéticos/efectos adversos , Contaminación de Medicamentos , Humanos , Mercadotecnía/normas , Preparaciones de Plantas/efectos adversos , Preparaciones de Plantas/normas , Estados Unidos , United States Food and Drug Administration , Vitaminas/efectos adversos , Vitaminas/normas
4.
Phytochem Anal ; 20(5): 365-71, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19533594

RESUMEN

INTRODUCTION: Knowledge of xylem sap chemical composition is important to the understanding of translocation, detoxification and tolerance mechanisms. However, the small amount of sample available often hampers its characterisation. Hence, low volume consumption techniques are needed for xylem sap analysis. OBJECTIVE: To develop a microsampling technique for the determination of elements in xylem sap from different plants by flame atomic absorption spectrometry (FAAS). METHODOLOGY: The microsampling device was optimised in terms of sample volume and integration time. The analytical characteristics of the microsampling technique (micro-FAAS) were established and compared with those of FAAS with traditional continuous nebulisation. The method was validated by means of an independent technique. RESULTS: Ca, Mg and Ni were determined in a 50 microL aliquot of xylem sap solution/element that was introduced directly into the flame via the microsampling accessory. Good precision was obtained with relative standard deviations of 1.1, 0.6 and 2.3% for Ca, Mg and Ni, respectively. Matrix effects resulting from the physical characteristics of the samples and possible chemical interferences caused by phosphate and/or sulphate were ruled out. CONCLUSION: A simple, rapid and reproducible microsampling technique coupled to FAAS was developed and successfully applied in the determination of Ca, Mg and Ni in xylem sap.


Asunto(s)
Calcio/análisis , Magnesio/análisis , Níquel/análisis , Espectrofotometría Atómica/métodos , Xilema/química , Brassicaceae/química , Calcio/normas , Calibración , Cistaceae/química , Magnesio/normas , Níquel/normas , Extractos Vegetales/análisis , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Estándares de Referencia , Reproducibilidad de los Resultados , Espectrofotometría Atómica/instrumentación
6.
Nutr Cancer ; 27(1): 41-7, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-8970180

RESUMEN

Oral submucous fibrosis (OSF) is an oral precancerous condition characterized by symptoms such as intolerance to spicy food, altered salivation, progressive difficulty in opening the mouth, and signs like vesiculation, ulceration, blanching, rigidity, and stiffening of the oral mucosa and depapillation and altered mobility of the tongue. It is seen mostly among people of Indian subcontinent origin. The major structural change is extensive fibroelastic scarring of the lamina propria and deeper connective tissues. A combination of micronutrients (vitamins A, B complex, C, D, and E) and minerals (iron, calcium, copper, zinc, magnesium, and others) was evaluated for its efficacy in controlling the symptoms and signs of OSF in 117 compliant subjects in Karachi, Pakistan, in a single-arm preliminary study. The subjects received supplementation for one to three years. Significant improvement in symptoms, notably intolerance to spicy food, burning sensation, and mouth opening, was observed at exit. The interincisor distance deteriorated in 11 subjects (10%) at exit; it was stable in 56 subjects (49%) and improved in 48 (41%). The mean interincisor distance was 19.1 +/- 10.8 (SD) mm at exit compared with 16.2 +/- 7.5 mm at baseline. A significant proportion of concomitant lesions like leukoplakia also regressed at exit. The major outcome from this study was a beneficial clinical response in subjects with OSF to multiple micronutrient intervention, which justifies its further evaluation in well-designed randomized controlled trials in other settings in South Asia.


Asunto(s)
Micronutrientes/farmacología , Minerales/farmacología , Fibrosis de la Submucosa Bucal/dietoterapia , Vitaminas/farmacología , Adolescente , Adulto , Ácido Ascórbico/sangre , Ácido Ascórbico/farmacología , Ácido Ascórbico/normas , Calcio/sangre , Calcio/farmacología , Calcio/normas , Niño , Preescolar , Cobre/sangre , Cobre/farmacología , Cobre/normas , Femenino , Alimentos Fortificados , Humanos , Lactante , Recién Nacido , Hierro/sangre , Hierro/farmacología , Hierro/normas , Magnesio/sangre , Magnesio/farmacología , Magnesio/normas , Masculino , Micronutrientes/normas , Minerales/sangre , Minerales/normas , Fibrosis de la Submucosa Bucal/epidemiología , Fibrosis de la Submucosa Bucal/patología , Pakistán/epidemiología , Vitamina A/sangre , Vitamina A/farmacología , Vitamina A/normas , Complejo Vitamínico B/sangre , Complejo Vitamínico B/farmacología , Complejo Vitamínico B/normas , Vitamina D/sangre , Vitamina D/farmacología , Vitamina D/normas , Vitamina E/sangre , Vitamina E/farmacología , Vitamina E/normas , Vitaminas/sangre , Vitaminas/normas , Zinc/sangre , Zinc/farmacología , Zinc/normas
7.
Rocz Panstw Zakl Hig ; 42(1): 33-40, 1991.
Artículo en Polaco | MEDLINE | ID: mdl-1788510

RESUMEN

Studies on the content of macrominerals in daily diets reconstructed in 1988 on the basis of the analysis of family budgets in 1986 carried out by the Central Statistical Bureau were carried on. Two social groups i.e. manual and mental workers with medium income were considered. The diets were prepared for 5 regions (Warszawa, Lublin, Olsztyn, Poznan, Wroclaw). According to the studies the requirements for calcium and magnesium were met in about 70% and those for iron in about 84%. The content of potassium in the diets was in the range of recommended allowances while the phosphorus exceeded the allowances by about 20-30%. The comparison of the presently studied diets with the ones from 1973, 1980, 1981 showed a lower degree of realization of the recommended intake of calcium and magnesium in 1986. The content of studied minerals in the diets was usually similar in all five regions.


Asunto(s)
Calcio/administración & dosificación , Servicios Dietéticos/normas , Hierro/administración & dosificación , Magnesio/administración & dosificación , Fenómenos Fisiológicos de la Nutrición , Servicios de Salud del Trabajador/normas , Fósforo/administración & dosificación , Potasio/administración & dosificación , Calcio/normas , Alimentos Fortificados/normas , Humanos , Hierro/normas , Magnesio/normas , Valor Nutritivo , Fósforo/normas , Polonia , Potasio/normas
8.
J Nutr ; 119(12 Suppl): 1846-51, 1989 12.
Artículo en Inglés | MEDLINE | ID: mdl-2693646

RESUMEN

Despite the use of metabolic balance studies and measurements of bone mineral content, it is difficult to assess the requirements of Ca and P in growing infants. From observations made forty years ago with cow's milk formulas it is obvious what is too much calcium and phosphorus in infant formulas. These observations were utilized in the development of "humanized cow's milk formulas" in the 1950s. Though the total concentrations of Ca and P have been greatly reduced in these formulas, the Ca/P ratio imbalance, compared to human milk, persists. Infants fed these formulas still receive a relative phosphorus load, and cases of neonatal tetany are still occasionally reported. Thus, formula-fed infants have higher serum P and lower serum Ca concentrations than do human milk-fed infants. Unlike Ca and P, the magnesium concentration of infant formulas is similar to that of human milk, and Mg toxicity from formulas has not been reported. Like Ca and P, however, it is difficult to determine the growing infant's requirement for magnesium. The available information does not favor either increasing or decreasing the present concentrations of Ca, P or Mg in infant formulas. The upper limit for these minerals should remain at the present concentrations: 45-50 mg/dl (65-75 mg/100 kcal) for Ca, 30-40 mg/dl (48-58 mg/100 kcal) for P and 12 mg/dl (18 mg/100 kcal) for Mg.


Asunto(s)
Calcio/normas , Alimentos Formulados/normas , Alimentos Infantiles/normas , Fenómenos Fisiológicos Nutricionales del Lactante , Magnesio/normas , Fósforo/normas , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Necesidades Nutricionales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA